Monocytes from infliximab-resistant patients with Crohn’s disease exhibit a disordered cytokine profile
Abstract Crohn's disease (CD) is a chronic inflammatory disorder characterized by immune response dysregulation. Tumor necrosis factor-α (TNFα) is a key cytokine in the pathogenesis of CD, as indicated by the efficacy of anti-TNF-α therapy with infliximab (IFX). However, approximately 30–40% of...
Guardado en:
Autores principales: | Federica Gaiani, Bianca Maria Rotoli, Francesca Ferrari, Amelia Barilli, Rossana Visigalli, Maria Clotilde Carra, Gian Luigi de’Angelis, Nicola de’Angelis, Valeria Dall’Asta |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8636936dc86841a397cc30500d3d886e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Epithelial to Mesenchymal Transition: A Challenging Playground for Translational Research. Current Models and Focus on <i>TWIST1</i> Relevance and Gastrointestinal Cancers
por: Luana Greco, et al.
Publicado: (2021) -
Maintenance treatment with infliximab for the management of Crohn&rsquo;s disease in adults
por: Renato Caviglia, et al.
Publicado: (2009) -
Decoupled choice-driven and stimulus-related activity in parietal neurons may be misrepresented by choice probabilities
por: Adam Zaidel, et al.
Publicado: (2017) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto S, et al.
Publicado: (2018) -
Infliximab en el tratamiento de la enfermedad de Crohn: Estudio preliminar
por: Gellona V,José, et al.
Publicado: (2006)